← Leaderboards
Justin Brooks
Tanzen Medical, Inc.
$951,472
Attributed
$951,472
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500.7K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
NIH$951,472 · 2
By mechanism
R43$951,472 · 2
Top collaborators
No co-investigators on record.
Most similar at Tanzen Medical, Inc.
Same institution · by research overlap
- Cody Gregory Feltch$486,552
- Cody Feltch$225,000
Others in their field
Other Rising Stars on “Wearable Device”
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Sunni L. Mumford · University Of Pennsylvania$6,439,627
- Farshad Tehrani · Actiox Llc$6,356,284
- Emily Rose Pfaff · University Of Colorado Denver$4,409,463
- Richard Austin Moffitt · University Of Colorado Denver$4,409,463
Research focus
Wearable DeviceSleepDevicesAlzheimer&AposDesignSleep DisordersSymptomsReportingQuality Of LifeAlgorithmsSensorClinical TrialsSignal TransductionSmall Business Innovation Research GrantFeasibility TestingPreservationComorbidityMeasurementEconomic BurdenData AggregationData ReportingBiological MarkersCommercializationAgitation
Grant awards (4)
Improved Patient Reported Outcomes (iPRO) -Sleep Diary: A Tool to Improve Sleep Assessment in Clinical Trials$103,891
R43 · FY2024 · HL · contact PI
Improved Patient Reported Outcomes (iPRO) -Sleep Diary: A Tool to Improve Sleep Assessment in Clinical Trials$291,872
R43 · FY2023 · HL · contact PI
RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Patients with Alzheimer's Disease$55,000
R43 · FY2023 · AG · contact PI
RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Patients with Alzheimer's Disease$500,709
R43 · FY2022 · AG · contact PI